Head-to-head · WeighScore
Joi + Blokes vs NiceRx
By GLP-1 ScorecardUpdated
Score comparison
NiceRx has the higher recorded score — 66.1/100 to 60/100.
NiceRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NiceRx (NiceRx LLC) offers compounded semaglutide ($199/mo) and compounded tirzepatide ($299/mo) with first-month promos.
Before you choose
Before comparing the headline prices, the Joi + Blokes review and the NiceRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Joi + Blokes vs Piper and LunaRx vs NiceRx compare each of them with another graded program, and the list of alternatives to Joi + Blokes ranks the programs closest to Joi + Blokes on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Live Vital review covers one graded close to these two, at 62.7/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Joi + Blokes | NiceRx |
|---|---|---|
| WeighScore | 60/100 | 66.1/100 |
| Grade | C | C |
| Site position | #360 | #220 |
| Semaglutide | $199/mo (promotional rate, quarterly plan, compounded) | $199/mo (compounded) |
| Tirzepatide | $299/mo (quarterly plan, compounded) | $299/mo (compounded) |
| Coverage | Coverage not published | 46 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
FDAWarning letter issued to Joi and Blokes dba Joi + Blokes in June 2026. See the FDA warning-letter database.
Strengths
- Separate programs for women (Joi) and men (Blokes) — most GLP-1 telehealth is gender-agnostic
- Trustpilot 4.6/5 from 1,254+ reviews — among the strongest review signals in the category
- Monthly price includes medication, dosing support, clinician consults, and health coaching
- Integrated hormone + GLP-1 programs help patients on testosterone or perimenopausal protocols
- First-month discount ($99 sema / $149 tirz) lowers the barrier to trying GLP-1s
What to consider
- Billed quarterly — a 3-month commitment up front, not month-to-month
- Different pricing in NY and NJ — verify your state's cost before committing
- Per-state availability isn't listed; it's zip-code gated behind signup
- Months 2+ cost more ($199 sema / $299 tirz) than the headline intro price
- FDA issued Joi and Blokes dba Joi + Blokes a warning letter in June 2026; the letter is public in FDA's warning-letter database
Strengths
- LegitScript approved
- Named legal entity (NiceRx LLC) with Boca Raton FL address
- First-month discount on both drugs
- Every batch tested for sterility and potency
- 46-state coverage
What to consider
- Not available in Alaska, Mississippi, New Jersey, Kansas
- Compounded only — no brand-name options
- Broader platform (anti-aging, NAD+, B12)
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.